PATENT CLAIM ANALYSIS

Application Number: 15775810
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "547000"]

Abstract:
The present invention provides methods for treating, controlling or mitigating paroxysmal nocturnal hemoglobinuria (PNH), comprising administering a monoacetyldiacylglycerol compound to a patient in need thereof, as well as compositions useful therefor.

Claim (Index 14):
The method of  claim 1  wherein the patient exhibits reduced or absent levels of GPI on erythrocyte membranes, e.g., wherein fluorescein-labelled proaerolysin (FLAER) is used to measure GPI levels on the erythrocytes.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15775811', '14936464', '14951353', '14912920', '14959750']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7630992289210914
- 35 USC 102 Novelty (BERT): 0.5651513409508874
- Combined Prediction Score: 0.7433044401240709
- Mean Citation Score: 340.9169940000001
- Max Citation Score: 453.0318
- Similarity Product: 317.40848427425624

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test